Literature DB >> 15890826

BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart.

Dillon Phan1, Tara L Rasmussen, Osamu Nakagawa, John McAnally, Paul D Gottlieb, Philip W Tucker, James A Richardson, Rhonda Bassel-Duby, Eric N Olson.   

Abstract

The vertebrate heart is assembled during embryogenesis in a modular manner from different populations of precursor cells. The right ventricular chamber and outflow tract are derived primarily from a population of progenitors known as the anterior heart field. These regions of the heart are severely hypoplastic in mutant mice lacking the myocyte enhancer factor 2C (MEF2C) and BOP transcription factors, suggesting that these cardiogenic regulatory factors may act in a common pathway for development of the anterior heart field and its derivatives. We show that Bop expression in the developing heart depends on the direct binding of MEF2C to a MEF2-response element in the Bop promoter that is necessary and sufficient to recapitulate endogenous Bop expression in the anterior heart field and its cardiac derivatives during mouse development. The Bop promoter also directs transcription in the skeletal muscle lineage, but only cardiac expression is dependent on MEF2. These findings identify Bop as an essential downstream effector gene of MEF2C in the developing heart, and reveal a transcriptional cascade involved in development of the anterior heart field and its derivatives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890826     DOI: 10.1242/dev.01849

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  41 in total

1.  skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.

Authors:  Chong Yon Park; Stephanie A Pierce; Morgan von Drehle; Kathryn N Ivey; Jayson A Morgan; Helen M Blau; Deepak Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-11       Impact factor: 11.205

Review 2.  Enhancer identification through comparative genomics.

Authors:  Axel Visel; James Bristow; Len A Pennacchio
Journal:  Semin Cell Dev Biol       Date:  2007-01-05       Impact factor: 7.727

Review 3.  Transcriptional pathways in second heart field development.

Authors:  Brian L Black
Journal:  Semin Cell Dev Biol       Date:  2007-01-17       Impact factor: 7.727

Review 4.  Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography.

Authors:  Antonio Vitarelli; Claudio Terzano
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

Review 5.  Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease.

Authors:  Miao Cui; Zhaoning Wang; Rhonda Bassel-Duby; Eric N Olson
Journal:  Development       Date:  2018-12-20       Impact factor: 6.868

6.  Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart.

Authors:  Junco S Warren; Christopher M Tracy; Mickey R Miller; Aman Makaju; Marta W Szulik; Shin-Ichi Oka; Tatiana N Yuzyuk; James E Cox; Anil Kumar; Bucky K Lozier; Li Wang; June García Llana; Amira D Sabry; Keiko M Cawley; Dane W Barton; Yong Hwan Han; Sihem Boudina; Oliver Fiehn; Haley O Tucker; Alexey V Zaitsev; Sarah Franklin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

7.  The transcription factor MEF2A fine-tunes gene expression in the atrial and ventricular chambers of the adult heart.

Authors:  Jose L Medrano; Francisco J Naya
Journal:  J Biol Chem       Date:  2017-10-20       Impact factor: 5.157

8.  Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c.

Authors:  Matthew J Potthoff; Michael A Arnold; John McAnally; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

9.  Cardiac deletion of Smyd2 is dispensable for mouse heart development.

Authors:  Florian Diehl; Mark A Brown; Machteld J van Amerongen; Tatyana Novoyatleva; Astrid Wietelmann; June Harriss; Fulvia Ferrazzi; Thomas Böttger; Richard P Harvey; Philip W Tucker; Felix B Engel
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

10.  SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.

Authors:  Dali Li; Zhiyv Niu; Weishi Yu; Yu Qian; Qian Wang; Qiang Li; Zhengfang Yi; Jian Luo; Xiushan Wu; Yuequn Wang; Robert J Schwartz; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.